Clinical Case Reports (Nov 2022)
Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports
Abstract
Abstract Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.
Keywords